Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.35 is 37% above its 5-year average of -2.16, near the high end of its 5-year range (-3.36–-1.35).
18.18% above its 12-month average of -1.65.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.38.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.35
EARNINGS PER SHARE (EPS) AVG TTM
-1.65
EARNINGS PER SHARE (EPS) AVG 3Y
-1.88
EARNINGS PER SHARE (EPS) AVG 5Y
-2.16
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.18%
CURRENT VS 3Y AVG
+28.10%
CURRENT VS 5Y AVG
+37.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
ORIC Pharmaceuticals, Inc.
Market Cap
$1.24B
Earnings Per Share (EPS)
-1.35
TTM Avg
-1.65
3Y Avg
-1.88
5Y Avg
-2.16
Market Cap
$1.23B
Earnings Per Share (EPS)
0.06
TTM Avg
-0.54
3Y Avg
-0.90
5Y Avg
-0.90
Market Cap
$1.23B
Earnings Per Share (EPS)
0.18
TTM Avg
0.04
3Y Avg
-0.14
5Y Avg
-0.31
Market Cap
$1.22B
Earnings Per Share (EPS)
-0.02
TTM Avg
-0.12
3Y Avg
-0.17
5Y Avg
-0.18
Market Cap
$1.21B
Earnings Per Share (EPS)
-2.40
TTM Avg
-1.76
3Y Avg
-1.59
5Y Avg
-1.20
Market Cap
$1.21B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.20
3Y Avg
-3.20
5Y Avg
-3.20
Market Cap
$1.20B
Earnings Per Share (EPS)
-124.78
TTM Avg
-85.76
3Y Avg
-67.06
5Y Avg
-58.99
Market Cap
$1.18B
Earnings Per Share (EPS)
-0.14
TTM Avg
0.06
3Y Avg
-0.09
5Y Avg
-0.17
Market Cap
$1.31B
Earnings Per Share (EPS)
-1.04
TTM Avg
-0.49
3Y Avg
-0.48
5Y Avg
-0.41
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.24B | -1.35 | -1.65 | -1.88 | -2.16 |
| Omada Health (OMDA)vs › | $1.23B | 0.06 | -0.54 | -0.90 | -0.90 |
| Cronos Group Inc. (CRON)vs › | $1.23B | 0.18 | 0.04 | -0.14 | -0.31 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.02 | -0.12 | -0.17 | -0.18 |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.21B | -2.40 | -1.76 | -1.59 | -1.20 |
| Kardigan, Inc. (KARD)vs › | $1.21B | N/A | -3.20 | -3.20 | -3.20 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | -124.78 | -85.76 | -67.06 | -58.99 |
| MannKind Corporation (MNKD)vs › | $1.18B | -0.14 | 0.06 | -0.09 | -0.17 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | -1.04 | -0.49 | -0.48 | -0.41 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | N/A | -2.33 | -2.33 | -2.33 |
Trailing EPS (TTM)
$-1.35
Forward EPS (Est.)
$-1.50
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.47 |
| 2024-12-31 | -1.83 |
| 2023-12-31 | -1.96 |
| 2022-12-31 | -2.25 |
| 2021-12-31 | -2.07 |
| 2020-12-31 | -3.36 |
| 2018-12-31 | -12.32 |
| 2017-12-31 | -15.62 |
